Inside America’s monkeypox crisis — and the mistakes that made it worse

Updated August 17, 2022 at 5:16 p.m. EDT|Published August 17, 2022 at 6:00 a.m. EDT
Colorized transmission electron micrograph of monkeypox virus particles (yellow) cultivated and purified from cell culture. (Video: NIAID/SCIENCE SOURCE)
24 min

The nation’s top health officials believed they had finally hit upon a solution to quell weeks of public criticism about the straggling government response to the monkeypox outbreak spreading across the country this summer.

They would stretch the nation’s limited supply of the only FDA-approved vaccine for monkeypox by splitting doses to cover five times as many people — an admission, after repeated reassurances by top government officials, that the United States did not have enough shots for every at-risk American, after all.